Amyloid proteins cause a number of progressive, degenerative diseases. Among these is
Alzheimer's disease (AD), the etiology of which is linked to the formation of neurotoxic
assemblies by the amyloid β‐protein (Aβ). The clinical importance of AD has stimulated
intense interest in the mechanisms of Aβ folding and self‐assembly. Studying these
phenomena in vitro requires the preparation of Aβ peptide stocks that are well defined and
display reproducible biophysical and biological behaviors. Unfortunately, the propensity of …